Post-effective Amendment to an S-8 Filing (s-8 Pos)
28 Abril 2017 - 10:20AM
Edgar (US Regulatory)
As filed with the Securities and Exchange Commission on April 28, 2017
Registration
No. 333-210192
Registration
No. 333-202644
Registration
No. 333-194134
Registration
No. 333-187226
Registration
No. 333-183131
Registration
No. 333-177606
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
POST-EFFECTIVE
AMENDMENT NO. 1
TO
FORM
S-8
REGISTRATION STATEMENT
Under
The
Securities Act of 1933
Post-Effective Amendment No. 1 to Form
S-8
Registration Statement
No. 333-210192
Post-Effective Amendment No. 1 to Form
S-8
Registration Statement
No. 333-202644
Post-Effective Amendment No. 1 to Form
S-8
Registration Statement
No. 333-194134
Post-Effective Amendment No. 1 to Form
S-8
Registration Statement
No. 333-187226
Post-Effective Amendment No. 1 to Form
S-8
Registration Statement
No. 333-183131
Post-Effective Amendment No. 1 to Form
S-8
Registration Statement
No. 333-177606
ZELTIQ
Aesthetics, Inc.
(Exact name of registrant as specified in its charter)
|
|
|
Delaware
|
|
27-0119051
|
(State or other jurisdiction of
incorporation or organization)
|
|
(IRS Employer
Identification No.)
|
4410 Rosewood Drive
Pleasanton, CA 94588
(Address of principal executive offices)
2012 Stock Plan
2011
Equity Incentive Plan
2011 Employee Stock Purchase Plan
2005 Stock Incentive Plan
(Full Title of the Plans)
A. Robert D.
Bailey
Chief Legal Officer and Corporate Secretary
Allergan plc
Morris
Corporate Center III
400 Interpace Parkway
Parsippany, New Jersey 07054
(Name and address of agent for service)
Telephone number, including area code, of agent for service:
(862)
261-7000
Copy to:
Andrew L. Bab
Debevoise & Plimpton LLP
919 Third Avenue
New
York, NY 10022
(212)
909-6323
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an
emerging growth company. See definitions of large accelerated filer, accelerated filer, smaller reporting company, and emerging growth company in Rule 12b-2 of the Exchange Act.
|
|
|
|
|
|
|
Large accelerated filer
|
|
☒
|
|
Accelerated filer
|
|
☐
|
|
|
|
|
Non-accelerated filer
|
|
☐ (Do not check if smaller reporting company)
|
|
Smaller reporting company
|
|
☐
|
|
|
|
|
|
|
|
|
Emerging growth company
|
|
☐
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨ ☐
DEREGISTRATION OF SECURITIES
ZELTIQ Aesthetics, Inc., an Delaware corporation (the
Company
) is filing these Post-Effective Amendments to each of the following
Registration Statements on Form
S-8
(collectively, the
Registration Statements
) to deregister any and all securities that remain unsold under such Registration Statements.
|
(1)
|
Registration Statement
No. 333-177606,
filed with the Securities and Exchange Commission (the
Commission
) on October 28, 2011, pertaining to the
registration of 4,895,069 shares of the Companys common stock under the Companys 2005 Stock Incentive Plan, 2,089,234 shares of the Companys common stock under the Companys 2011 Equity Incentive Plan and 870,018 shares of the
Companys common stock under the Companys 2011 Employee Stock Purchase Plan;
|
|
(2)
|
Registration Statement
No. 333-183131,
filed with the Commission on August 7, 2012 pertaining to the registration of 1,500,000 shares of the Companys common stock
under the Companys 2012 Stock Plan;
|
|
(3)
|
Registration Statement
No. 333-187226,
filed with the Commission on March 13, 2013, pertaining to the registration of 1,200,000 shares of the Companys common stock
under the Companys 2011 Equity Incentive Plan and 150,000 shares of the Companys common stock under the Companys 2011 Employee Stock Purchase Plan;
|
|
(4)
|
Registration Statement
No. 333-194134,
filed with the Commission on February 26, 2014, pertaining to the registration of 1,851,794 shares of the Companys common
stock under the Companys 2011 Equity Incentive Plan and 370,358 shares of the Companys common stock under the Companys 2011 Employee Stock Purchase Plan;
|
|
(5)
|
Registration Statement
No. 333-202644,
filed with the Commission on March 10, 2015, pertaining to the registration of 1,000,000 shares of the Companys common stock
under the Companys 2011 Equity Incentive Plan; and
|
|
(6)
|
Registration Statement
No. 333-210192,
filed with the Commission on March 15, 2016, pertaining to the registration of 1,000,000 shares of the Companys common stock
under the Companys 2011 Equity Incentive Plan.
|
On April 28, 2017 (the
Effective Date
), the Company
consummated the merger contemplated by the Agreement and Plan of Merger, dated as of February 13, 2017 (the
Merger Agreement
), by and among the Company, Allergan Holdco US, Inc., a Delaware corporation
(
Allergan
), and Blizzard Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of Allergan (
Merger Sub
). Pursuant to the terms of the Merger Agreement, Merger Sub merged with and into the
Company (the
Merger
), with the Company surviving the Merger as a wholly-owned subsidiary of Allergan.
As a result of the consummation
of the transactions contemplated by the Merger Agreement, the Company has terminated all offerings of the Companys securities pursuant to the Registration Statements. Accordingly, pursuant to the undertaking contained in the Registration
Statements to remove from registration, by means of a post-effective amendment, any of the securities being registered which remain unsold at the termination of the offering, the Company is filing these Post-Effective Amendments to deregister all of
the securities registered and reserved for issuance under the Registration Statements which remained unissued as of the Effective Date.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on
Form S-8
and has duly caused these Post-Effective Amendments to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Parsippany, State of New
Jersey, on April 28, 2017.
|
|
|
|
|
|
|
|
|
|
|
|
|
ZELTIQ AESTHETICS, INC.
|
Dated: April 28, 2017
|
|
|
|
|
|
|
|
|
|
|
|
|
/s/ A. Robert Bailey
|
|
|
|
|
|
|
A. Robert Bailey
|
|
|
|
|
|
|
President
|
Pursuant to the requirements of the Securities Act of 1933, this Post-Effective Amendment has been signed by the following
persons in the capacities and on the date indicated.
|
|
|
|
|
Signature
|
|
Capacity in Which Signed
|
|
Date
|
|
|
|
/s/ A. Robert Bailey
|
|
President
|
|
April 28, 2017
|
A. Robert Bailey
|
|
(
Principal Executive Officer
)
|
|
|
|
|
|
/s/ Stephen Kaufhold
|
|
Treasurer
|
|
April 28, 2017
|
Stephen Kaufhold
|
|
(
Principal Financial and Accounting Officer
)
|
|
|
|
|
|
/s/ Kira Schwartz
|
|
Secretary, Director
|
|
April 28, 2017
|
Kira Schwartz
|
|
|
|
|
|
|
|
/s/ Sigurd Kirk
|
|
Vice President, Director
|
|
April 28, 2017
|
Sigurd Kirk
|
|
|
|
|
Zeltiq Aesthetics, Inc. (NASDAQ:ZLTQ)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Zeltiq Aesthetics, Inc. (NASDAQ:ZLTQ)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024